Arbeitspapier

The Effect of Intellectual Property Rights on Domestic Innovation in the Pharmaceutical Sector

This paper analyses the causal impact of Intellectual Property Rights (IPR) on pharmaceutical innovation in a panel of 74 countries. The identification strategy exploits the different timing across countries of two sets of IPR reforms. Domestic innovation is measured as citation-weighted domestic patents filed at the European Patent Office (EPO): to account for their distribution, count data models are used. A Zero Inated Negative Binomial model is adopted to consider the choice not to patent at the EPO. Results show that, in the short-run, IPR stimulate innovation. The effect for developing countries is roughly half of that for developed countries.

Sprache
Englisch

Erschienen in
Series: CESifo Working Paper ; No. 6004

Klassifikation
Wirtschaft
Intellectual Property and Intellectual Capital
Innovation and Invention: Processes and Incentives
Health: Government Policy; Regulation; Public Health
Property Law
Thema
intellectual property rights
developing countries
pharmaceutical sector
innovation
patents
TRIPS

Ereignis
Geistige Schöpfung
(wer)
Gamba, Simona
Ereignis
Veröffentlichung
(wer)
Center for Economic Studies and ifo Institute (CESifo)
(wo)
Munich
(wann)
2016

Handle
Letzte Aktualisierung
10.03.2025, 11:45 MEZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.

Objekttyp

  • Arbeitspapier

Beteiligte

  • Gamba, Simona
  • Center for Economic Studies and ifo Institute (CESifo)

Entstanden

  • 2016

Ähnliche Objekte (12)